Symtuza 800 MG / 150 MG / 200 MG / 10 MG Oral Tablet

RxCUI: 2049677
RxNorm name: Symtuza 800 MG / 150 MG / 200 MG / 10 MG Oral Tablet
Display name: Symtuza 800 MG / 150 MG / 200 MG / 10 MG Oral Tablet
Full name: Symtuza 800 MG / 150 MG / 200 MG / 10 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Symtuza	DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE	Janssen Products LP	85a17d00-6b7c-41ea-a6b3-5ad924820dab	2026-04-17	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2049677

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
85a17d00-6b7c-41ea-a6b3-5ad924820dab	Symtuza 800 MG / 150 MG / 200 MG / 10 MG Oral Tablet	PSN	23	These highlights do not include all the information needed to use SYMTUZA safely and effectively. See full prescribing information for SYMTUZA. SYMTUZA ® (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018	20260417
85a17d00-6b7c-41ea-a6b3-5ad924820dab	Symtuza (cobicistat 150 MG / as darunavir ethanolate 800 MG / emtricitabine 200 MG / as tenofovir alafenamide fumarate 10 MG ) Oral Tablet	SY	23	These highlights do not include all the information needed to use SYMTUZA safely and effectively. See full prescribing information for SYMTUZA. SYMTUZA ® (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018	20260417
85a17d00-6b7c-41ea-a6b3-5ad924820dab	cobicistat 150 MG / darunavir 800 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG Oral Tablet [Symtuza]	SBD	23	These highlights do not include all the information needed to use SYMTUZA safely and effectively. See full prescribing information for SYMTUZA. SYMTUZA ® (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018	20260417